Are generic drugs being delayed to market?
Are less-expensive generic drugs being delayed to market by so-called "pay for delay" deals between drug companies? The deals happen after generic drug companies challenge the patents on brand-name drugs. The settlements include a date that the generic drug can enter the market, and in some cases, a payment from brand company to the generic company.
The full episode is no longer available for online streaming. Why?
Please continue to enjoy extra(s) from this episode.